TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable November 20, 1998
TCL Archive In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers October 4, 1996
TCL Archive In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care October 24, 1975
